Desh Rakshak Aushdhalaya Share Price

  • 38.09-0.77 (-1.98%)
  • Volume: 100
BSE
  • Closed
  • Last Updated On: 02 Jun, 2025, 02:16 PM IST
Loading...
Desh Rakshak Aushdhalaya Share Price
  • 38.09-0.77 (-1.98%)
  • Volume: 100
Advertisment

Desh Rakshak share price insights

  • Company has spent 4.75% of its operating revenues towards interest expenses and 15.41% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Desh Rakshak Aushdhalaya Ltd. share price moved down by -1.98% from its previous close of Rs 38.86. Desh Rakshak Aushdhalaya Ltd. stock last traded price is 38.09

    Share PriceValue
    Today/Current/Last-38.09
    Previous Day-38.86

InsightsDesh Rakshak

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    23.63
    EPS - TTM
    (₹)
    1.61
    MCap
    (₹ Cr.)
    17.25
    Sectoral MCap Rank
    161
    PB Ratio
    (x)
    2.53
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months0.00
    1 Year-0.02
    3 Years-0.02

    -
    VWAP
    (₹)
    38.09
    52W H/L
    (₹)
    41.49 / 7.65

    Desh Rakshak Share Price Returns

    1 Day-1.98%
    1 WeekN.A.
    1 Month-4.54%
    3 MonthsN.A.
    1 YearN.A.
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Desh Rakshak belongs to analysts' top-rated companies list?

    View Stock Screeners

    Desh Rakshak Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Desh Rakshak Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Desh Rakshak Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 4.75% of its operating revenues towards interest expenses and 15.41% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualJun 2015Mar 2015
      Total Income0.981.39
      Total Income Growth (%)-28.9823.26
      Total Expenses0.951.29
      Total Expenses Growth (%)-26.3616.58
      EBIT0.030.10
      EBIT Growth (%)-64.07432.04
      Profit after Tax (PAT)0.010.04
      PAT Growth (%)-76.24129.55
      EBIT Margin (%)3.516.95
      Net Profit Margin (%)0.972.91
      Basic EPS (₹)0.000.00
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income4.401.901.191.082.49
      Total Income Growth (%)131.8359.839.81-56.4653.21
      Total Expenses3.741.700.960.922.17
      Total Expenses Growth (%)120.2776.145.26-57.8157.92
      EBIT0.660.200.220.170.31
      EBIT Growth (%)229.68-10.4034.92-47.0726.99
      Profit after Tax (PAT)0.360.120.150.090.16
      PAT Growth (%)197.50-17.6556.06-42.7322.67
      EBIT Margin (%)15.0310.5718.8515.3512.62
      Net Profit Margin (%)8.106.3112.258.626.55
      Basic EPS (₹)0.800.270.330.210.37
      Quarterly | Annual FY 2015
      Total Revenue4.46
      Total Revenue Growth (%)11.44
      Total Expenses4.38
      Total Expenses Growth (%)12.79
      Profit after Tax (PAT)0.02
      PAT Growth (%)-64.25
      Operating Profit Margin (%)4.41
      Net Profit Margin (%)0.54
      Basic EPS (₹)0.05
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue6.306.036.186.206.61
      Total Revenue Growth (%)4.54-2.47-0.21-6.3129.74
      Total Expenses5.745.525.705.636.07
      Total Expenses Growth (%)3.91-3.141.36-7.2628.52
      Profit after Tax (PAT)0.480.430.410.480.42
      PAT Growth (%)11.485.39-15.7214.5537.88
      Operating Profit Margin (%)13.7514.3514.3712.9310.54
      Net Profit Margin (%)7.607.116.567.776.36
      Basic EPS (₹)1.070.960.911.080.95

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2015
      Total Assets9.59
      Total Assets Growth (%)2.73
      Total Liabilities2.77
      Total Liabilities Growth (%)-
      Total Equity6.82
      Total Equity Growth (%)0.35
      Current Ratio (x)2.28
      Total Debt to Equity (x)0.16
      Contingent Liabilities0.00
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets17.9816.3215.7416.1214.57
      Total Assets Growth (%)10.173.68-2.3610.6418.26
      Total Liabilities8.026.846.616.845.77
      Total Liabilities Growth (%)17.253.48-3.3618.5446.82
      Total Equity9.969.489.139.298.80
      Total Equity Growth (%)5.063.83-1.725.575.01
      Current Ratio (x)1.611.482.062.191.96
      Total Debt to Equity (x)0.310.300.450.470.33
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2015
      Net Cash flow from Operating Activities0.00
      Net Cash used in Investing Activities0.00
      Net Cash flow from Financing Activities0.00
      Net Cash Flow0.00
      Closing Cash & Cash Equivalent-
      Closing Cash & Cash Equivalent Growth (%)-
      Total Debt/ CFO (x)-
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-0.301.520.450.230.84
      Net Cash used in Investing Activities-0.02-0.09-0.78-1.95-1.26
      Net Cash flow from Financing Activities0.25-1.340.151.350.80
      Net Cash Flow-0.070.09-0.18-0.360.37
      Closing Cash & Cash Equivalent0.070.140.050.230.59
      Closing Cash & Cash Equivalent Growth (%)-50.68165.23-77.43-61.39169.99
      Total Debt/ CFO (x)-10.211.839.1218.543.46

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2015
      Return on Equity (%)0.35
      Return on Capital Employed (%)2.59
      Return on Assets (%)0.25
      Interest Coverage Ratio (x)5.57
      Asset Turnover Ratio (x)-
      Price to Earnings (x)175.44
      Price to Book (x)0.61
      EV/EBITDA (x)7.65
      EBITDA Margin (%)14.53
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)4.784.534.465.214.80
      Return on Capital Employed (%)6.617.006.675.885.90
      Return on Assets (%)2.652.612.572.982.88
      Interest Coverage Ratio (x)4.293.663.265.196.44
      Asset Turnover Ratio (x)0.370.370.390.400.49
      Price to Earnings (x)29.507.595.983.974.54
      Price to Book (x)1.410.340.270.210.22
      EV/EBITDA (x)13.314.534.875.014.39
      EBITDA Margin (%)20.3921.6421.5119.3214.54

    Financial InsightsDesh Rakshak

    • Income (P&L)
      • Employee & Interest Expense

        Company has spent 4.75% of its operating revenues towards interest expenses and 15.41% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Desh Rakshak Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Desh Rakshak Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Desh Rakshak23.632.484.786.612.650.5713.757.601.071.610.31-10.21
      Kabra Drugs-25.4025.28-4.40-4.40-4.300.000.000.00-0.9943.840.02-0.09
      Chemo Pharma57.405.35-39.44-35.51-37.44-7.650.000.00-9.6628.820.000.00
      Colinz Labs31.741.665.246.854.20-1.5010.137.601.974.170.07-0.44
      Rubra Medica383.4318.294.558.583.89-36.799.585.080.056.920.000.00
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Unjha Form
      • Kamron Labs.
      • Vivanza Biosciences
      • Ortin Labs
      • Avon Lifesciences

      Choose from Stocks

      Peers InsightsDesh Rakshak

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Desh Rakshak Shareholding Pattern

        • Loading...
          Showing Desh Rakshak Shareholding as on Mar 2025
          CategoryMar 2025Dec 2024Sep 2024Jun 2024
          Promoters64.2864.2864.2864.28
          Pledge0.000.000.000.00
          FII0.000.000.000.00
          DII0.000.000.000.00
          Mutual Funds0.000.000.000.00
          Others35.7235.7235.7235.72
        • Showing Shareholding as on Mar 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters28,53,10064.28 %0.00
          Pledge00.00 %0.00
          Others15,85,22435.72 %0.00

        Desh Rakshak MF Ownership

        MF Ownership details are not available.

        Desh Rakshak Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          May 30, 2025May 26, 2025Board MeetingAudited Results
          May 29, 2025May 05, 2025EGM-
          May 05, 2025Apr 28, 2025Board MeetingOthers
          Apr 11, 2025Apr 04, 2025Board MeetingTo consider Fund Raising & Others
          Feb 13, 2025Feb 06, 2025Board MeetingQuarterly Results
        • Dividend announcements are not available.

        • No other corporate actions details are available.

        About Desh Rakshak

        Desh Rakshak Aushdhalaya Ltd., incorporated in the year 1981, is a Small Cap company (having a market cap of Rs 16.91 Crore) operating in Pharmaceuticals sector. Desh Rakshak Aushdhalaya Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2024. Show More

        • Executives

        • Auditors

        • TK

          Tosh Kumar Jain

          Chairman & Managing Director
          AK

          Arihant Kumar Jain

          Whole Time Director
          MJ

          Monika Jain

          Whole Time Director
          BP

          Bhumika Parwani

          Non Executive Woman Director
          Show More
        • Anil Jain & Co
          Sudhanshu Jian & Associates

        FAQs about Desh Rakshak share

        • 1. What is Desh Rakshak share price and what are the returns for Desh Rakshak share?
          As on 02 Jun, 2025, 02:16 PM IST Desh Rakshak share price is down by 1.98% basis the previous closing price of Rs 38.86. Desh Rakshak share price is Rs 38.09. Return Performance of Desh Rakshak Shares:
          • 1 Month: Desh Rakshak share price moved down by 4.54%
        • 2. Who are the key owners of Desh Rakshak stock?
          Promoter, owns 64.28, shares of Desh Rakshak as on 31 Mar 2025
          • There is no change in promoter holding from 31 Dec 2024 to 31 Mar 2025
          • There is no change in Other investor holding from 31 Dec 2024 to 31 Mar 2025
        • 3. What are the returns for Desh Rakshak share?
          Return Performance of Desh Rakshak Shares:
          • 1 Month: Desh Rakshak share price moved down by 4.54%
        • 4. What are the key metrics to analyse Desh Rakshak Share Price?
          Desh Rakshak share can be quickly analyzed on following metrics:
          • Stock's PE is 23.63
          • Price to Book Ratio of 2.53
        • 5. What is the CAGR of Desh Rakshak?
          The CAGR of Desh Rakshak is -2.32.
        • 6. Who's the chairman of Desh Rakshak?
          Tosh Kumar Jain is the Chairman & Managing Director of Desh Rakshak
        • 7. What is Desh Rakshak's 52 week high / low?
          Desh Rakshak share price saw a 52 week high of Rs 41.49 and 52 week low of Rs 7.65.
        • 8. What are the Desh Rakshak quarterly results?
          On Standalone basis, Desh Rakshak reported a total income and profit of Rs 4.40 Cr and Rs 0.36 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2025-03-31 was Rs 6.30 Cr and Rs 0.48 Cr.
        • 9. What is the PE & PB ratio of Desh Rakshak?
          The PE ratio of Desh Rakshak stands at 23.63, while the PB ratio is 1.87.
        • 10. What is the market cap of Desh Rakshak?
          Market Capitalization of Desh Rakshak stock is Rs 17.25 Cr.
        • 11. Who are the peers for Desh Rakshak in Pharmaceuticals sector?
          Within Pharmaceuticals sector Desh Rakshak, Kabra Drugs Ltd., Adline Chem Lab Ltd., Vivanza Biosciences Ltd., Chemo Pharma Laboratories Ltd., Unjha Formulations Ltd., MPS Pharma Ltd., Ortin Global Ltd., Kobo Biotech Ltd., Colinz Laboratories Ltd. and Checkpoint Trends Ltd. are usually compared together by investors for analysis.

        Trending in Markets

        Top Gainers As on 03:59 PM | 13 Jun 2025

        Jubilant Ingrevia793.55
        111.55 (16.36%)
        SCI227.06
        20.75 (10.06%)
        DB Realty239.93
        15.88 (7.09%)
        360 One Wam1,140.50
        59.10 (5.47%)
        Narayana Hruday1,913.00
        88.60 (4.86%)

        Top Losers As on 03:59 PM | 13 Jun 2025

        Tata Teleservices71.60
        -5.31 (-6.90%)
        IREDA167.26
        -8.30 (-4.73%)
        InterGlobe5,262.00
        -214.50 (-3.92%)
        Reliance Power67.05
        -2.68 (-3.83%)
        Canara Bank111.46
        -4.19 (-3.62%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times